Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biocardia Inc (BCDA)

Biocardia Inc (BCDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,343
  • Shares Outstanding, K 17,446
  • Annual Sales, $ 1,020 K
  • Annual Income, $ -12,620 K
  • 60-Month Beta 1.40
  • Price/Sales 23.72
  • Price/Cash Flow N/A
  • Price/Book 3.46
Trade BCDA with:

Options Overview Details

View History
  • Implied Volatility 207.32% ( -52.63%)
  • Historical Volatility 106.22%
  • IV Percentile 89%
  • IV Rank 19.96%
  • IV High 854.74% on 05/09/22
  • IV Low 45.92% on 05/19/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 3,971
  • Open Int (30-Day) 3,989

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.23
  • Number of Estimates 3
  • High Estimate -0.10
  • Low Estimate -0.40
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -15.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1001 +32.72%
on 05/12/22
1.7500 -16.57%
on 04/27/22
+0.0200 (+1.39%)
since 04/18/22
3-Month
1.1001 +32.72%
on 05/12/22
2.8500 -48.77%
on 04/12/22
-0.6300 (-30.14%)
since 02/18/22
52-Week
1.1001 +32.72%
on 05/12/22
5.0988 -71.37%
on 06/21/21
-2.2300 (-60.43%)
since 05/18/21

Most Recent Stories

More News
BioCardia, Inc. (BCDA) Reports Q1 Loss, Lags Revenue Estimates

BioCardia, Inc. (BCDA) delivered earnings and revenue surprises of -26.67% and 68.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

BCDA : 1.4600 (-3.31%)
LCTX : 1.1400 (-5.00%)
BioCardia Reports First Quarter 2022 Business Highlights and Financial Results

SUNNYVALE, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the...

BCDA : 1.4600 (-3.31%)
Will High Costs & Low Sales Dent Braskem (BAK) Q1 Earnings?

Braskem's (BAK) upward cost trajectory is likely to have continued in the first quarter due to higher feedstock prices in international markets and global supply chain constraints.

BAK : 17.14 (-4.35%)
BCDA : 1.4600 (-3.31%)
HPK : 25.00 (-1.26%)
BLND : 3.31 (-2.93%)
Ovintiv (OVV) Q1 Earnings Coming Up: Here's How It Will Fare

Ovintiv's (OVV) first-quarter earnings are expected to have benefited from the surge in oil and natural gas prices.

BCDA : 1.4600 (-3.31%)
OVV : 44.05 (-2.80%)
HPK : 25.00 (-1.26%)
BLND : 3.31 (-2.93%)
Will Suncor (SU) Reverse the Previous Miss in Q1 Earnings?

Suncor Energy (SU) is expected to have benefited from the surge in oil realizations.

SU : 37.10 (-1.70%)
BCDA : 1.4600 (-3.31%)
HPK : 25.00 (-1.26%)
BLND : 3.31 (-2.93%)
BioCardia to Host Q1 2022 Financial Results and Corporate Update Conference Call on May 11, 2022

SUNNYVALE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the...

BCDA : 1.4600 (-3.31%)
BioCardia (BCDA) Gains FDA Nod for ARDS Cell Therapy Study

BioCardia (BCDA) gets FDA approval to start a phase I/II study to evaluate its allogenic stem cell therapy candidate, BCDA-04, in patients with ARDS due to COVID-19.

NVS : 88.04 (+0.41%)
MESO : 3.58 (-2.45%)
BCDA : 1.4600 (-3.31%)
ENLV : 3.84 (-3.03%)
BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress due to COVID-19

Phase I/II trial initiation expected in 3Q 2022...

BCDA : 1.4600 (-3.31%)
BioCardia Reports 2021 Financial Results and Recent Business Highlights

SUNNYVALE, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the...

BCDA : 1.4600 (-3.31%)
BioCardia Announces New Center for Medicare and Medicaid Services Reimbursement Code Applicable to the CardiAMP Cell Therapy Procedure

New Procedure Reimbursement Code Expected to Enhance Study Performance for Clinical Centers Participating in the CardiAMP Cell Therapy Heart Failure Trial...

BCDA : 1.4600 (-3.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California....

See More

Key Turning Points

3rd Resistance Point 1.5500
2nd Resistance Point 1.5300
1st Resistance Point 1.4950
Last Price 1.4600
1st Support Level 1.4400
2nd Support Level 1.4200
3rd Support Level 1.3850

See More

52-Week High 5.0988
Fibonacci 61.8% 3.5713
Fibonacci 50% 3.0995
Fibonacci 38.2% 2.6276
Last Price 1.4600
52-Week Low 1.1001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar